Antibiotic (combination) | Susceptible E. cloacae (n = 2075 unique patients, 3030 isolates) | Multi-resistant E. cloacae (n = 373 patients, 1373 isolates) | Selected for WGS (n = 112 isolates) | ||
---|---|---|---|---|---|
Patients (n) tested | % non-susceptible / positivea | Patients (n) tested | % non- susceptible / positivea | % non- susceptible / positivea | |
ciprofloxacin | 2075 | 1.3 | 373 | 42.9 | 28.6 |
colistin | 1122 | 0 | 205 | 68.8 | 78.4b |
gentamicin | 2075 | 0.2 | 373 | 82.8 | 86.6 |
imipenem | 2070 | 0.2 | 373 | 5.6 | 6.3 |
meropenem | 2073 | 0.1 | 373 | 4.8 | 6.3 |
tobramycin | 2075 | 0 | 373 | 89.3 | 87.5 |
trimethoprim/ sulfamethoxazole | 2075 | 5.5 | 373 | 34.6 | 86.6 |
ESBL production | 873 | 0 | 156 | 71.2 | 72.3 |
CIP or SXT | 2075 | 0.6 | 373 | 17.7 | 5.4 |
CIP or SXT or MEM | 2064 | 0 | 349 | 0.9 | 0 |
CIP or SXT or MEM or CST | 1118 | 0 | 187 | 0.5 | 0 |